Published in Br J Haematol on October 01, 1998
X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet (2001) 10.92
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther (2011) 5.44
Susceptible chiasmate configurations of chromosome 21 predispose to non-disjunction in both maternal meiosis I and meiosis II. Nat Genet (1996) 3.13
Linkage relationships of paraoxonase (PON) with other markers: indication of PON-cystic fibrosis synteny. Clin Genet (1985) 2.96
Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat Med (1996) 2.71
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia (2009) 2.30
Ribosomal mutations affecting efficiency of amber suppression. J Mol Biol (1970) 2.18
Molecular genetic approach to the characterization of the "Down syndrome region" of chromosome 21. Genomics (1989) 2.16
Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma. J Clin Oncol (2000) 2.12
Non-disjunction of chromosome 21 in maternal meiosis I: evidence for a maternal age-dependent mechanism involving reduced recombination. Hum Mol Genet (1994) 2.07
Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update. Clin Pharmacol Ther (2013) 1.99
Transient pancytopenia preceding acute lymphoblastic leukaemia (pre-ALL) precipitated by parvovirus B19. Br J Haematol (2001) 1.81
Origin and mechanisms of non-disjunction in human autosomal trisomies. Hum Reprod (1998) 1.81
The meiotic stage of nondisjunction in trisomy 21: determination by using DNA polymorphisms. Am J Hum Genet (1992) 1.67
Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine. Gut (2003) 1.66
Non-disjunction of chromosome 18. Hum Mol Genet (1998) 1.62
Mitochondrial deafness. Clin Genet (2007) 1.61
Azathioprine treatment during lactation. Aliment Pharmacol Ther (2008) 1.59
Characterization of susceptible chiasma configurations that increase the risk for maternal nondisjunction of chromosome 21. Hum Mol Genet (1997) 1.57
Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome. Oncogene (2010) 1.57
Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther (1997) 1.56
The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol (1991) 1.55
Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations. J Med Genet (2001) 1.46
Infectious exposure in the first years of life and risk of central nervous system tumours in children: analysis of birth order, childcare attendance and seasonality of birth. Br J Cancer (2010) 1.45
Angelman syndrome with uniparental disomy due to paternal meiosis II nondisjunction. Clin Genet (1999) 1.44
A polymorphic SstI site within the human ets-1 gene in the 11q23 region. Nucleic Acids Res (1986) 1.43
Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma. J Clin Oncol (1994) 1.41
Patterns of meiotic recombination on the long arm of human chromosome 21. Genome Res (2000) 1.40
t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol (1997) 1.39
Mechanisms of ring chromosome formation in 11 cases of human ring chromosome 21. Am J Hum Genet (1992) 1.38
Clinical and molecular aspects of aniridia. Clin Genet (2010) 1.34
Interstitial deletion 1p in a 30 year old woman. J Med Genet (1987) 1.29
Linkage of cystic fibrosis to the pro alpha 2(I) collagen gene, COL1A2, on chromosome 7. Cytogenet Cell Genet (1986) 1.29
Analysis of DNA polymorphisms suggests that most de novo dup(21q) chromosomes in patients with Down syndrome are isochromosomes and not translocations. Am J Hum Genet (1990) 1.27
Clinical and molecular characterisation of 80 patients with 5p deletion: genotype-phenotype correlation. J Med Genet (2001) 1.26
A linkage map of human chromosome 21:43 PCR markers at average intervals of 2.5 cM. Genomics (1993) 1.26
Analysis of specific misreading in Escherichia coli. J Mol Biol (1973) 1.26
Clinical trials with retinoids for breast cancer chemoprevention. Endocr Relat Cancer (2006) 1.25
Evolutionary relationships between the t and H-2 haplotypes in the house mouse. Immunogenetics (1984) 1.24
Erythrapheresis in patients with polycythaemia secondary to hypoxic lung disease. Br Med J (Clin Res Ed) (1983) 1.23
Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment. Neurology (2004) 1.23
Mutation analysis of TMC1 identifies four new mutations and suggests an additional deafness gene at loci DFNA36 and DFNB7/11. Clin Genet (2008) 1.21
Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/l. Hum Reprod (2003) 1.21
Clinical, cytogenetic, and molecular diagnosis of Angelman syndrome: estimated prevalence rate in a Danish county. Am J Med Genet (1995) 1.21
Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarrays. Leukemia (2004) 1.19
On the mechanism of spontaneous reversion and genetic recombination in bacteriophage T4. Genetics (1965) 1.18
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants. Leukemia (1998) 1.16
Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism. Cancer (1999) 1.13
Pharmacokinetics, dose adjustments, and 6-mercaptopurine/methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency. Acta Paediatr (1998) 1.12
Maternal meiosis I non-disjunction of chromosome 15: dependence of the maternal age effect on level of recombination. Hum Mol Genet (1998) 1.12
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Blood (2000) 1.10
Childcare in the first 2 years of life reduces the risk of childhood acute lymphoblastic leukemia. Leukemia (2007) 1.08
Linkage mapping of the highly informative DNA marker D21S156 to human chromosome 21 using a polymorphic GT dinucleotide repeat. Genomics (1990) 1.08
On the political economy of risk: farmworkers, pesticides, and dollars. Int J Health Serv (1982) 1.07
An extensive search for RFLP in the human glucose-6-phosphate dehydrogenase locus has revealed a silent mutation in the coding sequence. Am J Hum Genet (1988) 1.07
New assignment of the adenosine deaminase gene locus to chromosome 20q13 X 11 by study of a patient with interstitial deletion 20q. J Med Genet (1987) 1.04
Mutation analysis of the NSD1 gene in a group of 59 patients with congenital overgrowth. Am J Med Genet A (2005) 1.04
High frequency of the TARDBP p.Ala382Thr mutation in Sardinian patients with amyotrophic lateral sclerosis. Clin Genet (2011) 1.03
Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92. Leukemia (2002) 1.03
Molecular and clinical correlation study of Williams-Beuren syndrome: No evidence of molecular factors in the deletion region or imprinting affecting clinical outcome. Am J Med Genet (1999) 1.03
High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia. Leukemia (2006) 1.02
An immunohistological and genotypic study of the plasma cell form of Castleman's disease. Histopathology (1989) 1.02
Neurological deficit associated with Mycoplasma pneumoniae reversed by plasma exchange. Br Med J (Clin Res Ed) (1983) 1.02
Prenatal diagnosis of hypochondroplasia: report of two cases. Am J Med Genet A (2006) 1.01
Cost-effective multiplexing before capture allows screening of 25 000 clinically relevant SNPs in childhood acute lymphoblastic leukemia. Leukemia (2011) 1.01
'Educational symposium on long-term results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985-2000)'. Leukemia (2010) 1.00
Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia. Br J Cancer (2003) 0.98
Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system. Br J Haematol (2001) 0.98
Scratch induction in the rat by intradermal serotonin: a model for pruritus. Acta Derm Venereol (2001) 0.98
A report of pure 7p duplication syndrome and review of the literature. Am J Med Genet A (2006) 0.98
Comparative study of bactericidal activities, postantibiotic effects, and effects of bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae. Antimicrob Agents Chemother (1997) 0.98
Insulin dependent diabetes mellitus (IDDM) and autoimmune thyroiditis in a boy with a ring chromosome 18: additional evidence of autoimmunity or IDDM gene(s) on chromosome 18. J Med Genet (1999) 0.97
Origin of nondisjunction in trisomy 8 and trisomy 8 mosaicism. Eur J Hum Genet (1999) 0.97
Evolution of mouse major histocompatibility complex genes borne by t chromosomes. Proc Natl Acad Sci U S A (1985) 0.97
Molecular definition of a narrow interval at 7q22.1 associated with myelodysplasia. Blood (1996) 0.97
Early glycoxidation damage in brains from Down's syndrome. Biochem Biophys Res Commun (1998) 0.96
CD3G is within 200 kb of the leukemic t(4;11) translocation breakpoint. Genes Chromosomes Cancer (1991) 0.96
Clinical variability of genetic isolates of Cohen syndrome. Clin Genet (2011) 0.96
Ring chromosome 13: lack of distinct syndromes based on different breakpoints on 13q. J Med Genet (1992) 0.96
A novel presenilin 1 L166H mutation in a pseudo-sporadic case of early-onset Alzheimer's disease. Neurol Sci (2005) 0.95
DNA polymorphism analysis in families with recurrence of free trisomy 21. Am J Hum Genet (1992) 0.95
Isochromosome not translocation in trisomy 21q21q. Hum Genet (1989) 0.95
The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005. Leukemia (2005) 0.95
The homeobox gene MEIS1 is amplified in IMR-32 and highly expressed in other neuroblastoma cell lines. Eur J Cancer (2000) 0.95
Parental age and the origin of trisomy 21. A study of 302 families. Hum Genet (1989) 0.95
Hepatoblastoma in the Nordic countries. Int J Cancer (2012) 0.94
Clinical and molecular findings in IPEX syndrome. Arch Dis Child (2006) 0.94
Localization of Jacobsen syndrome breakpoints on a 40-Mb physical map of distal chromosome 11q. Genome Res (1999) 0.93
Mosaicism for the full mutation and a microdeletion involving the CGG repeat and flanking sequences in the FMR1 gene in eight fragile X patients. Am J Med Genet (1999) 0.93
Molecular cytogenetic characterization and origin of two de novo duplication 9p cases. Am J Med Genet (2000) 0.93
Variability of polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicentre study. Ann Oncol (1999) 0.92
"Compensatory" uniparental disomy of chromosome 21 in two cases. J Med Genet (1994) 0.92